Diabetic Macular Edema Market

Key Insights

The global Diabetic Macular Edema Market is valued at USD 4120.9 Million in 2024 and is projected to reach a value of USD 4875 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 1.55% between 2025 and 2035.

Overview and Description

Diabetic Macular Edema (DME) is an accumulation of fluid in the macula part of the retina that controls our most detailed vision abilities, due to leaking blood vessels. In order to develop DME, you must first have diabetic retinopathy.

The Global Diabetic Macular Edema Market is segmented based on products, applications, regions, and countries. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. All the segments have been analyzed based on present and future trends. The research study provides complete assessment of the market on the basis of competition, drivers, restraints, opportunities, trends, and industry-authenticated data. The market is estimated from 2018 to 2022 with forecast from 2023 to 2032.

COVID-19 Impact Analysis

COVID-19 pandemic led to government of numerous countries across the globe to impose strict lockdown restrictions during the preliminary stages. In 2021, numerous countries faced the adverse effects of the pandemic due to the outbreak of second wave, which also led governments to again impose lockdown measures. Business shutdowns, partial business operations, and travel restrictions have led to challenges in supply chain and in turn production. However, it is expected that reopening of trade activities, the market will witness steady growth in the demand in the coming years. Impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.

The report provides a completely separate chapter for COVID-19 Impact Analysis. This chapter includes:

• Impact Assessment of COVID-19 Pandemic
• Pre & Post COVID-19 Market Size
• Qualitative analysis on the short term & long term impact of COVID-19 on the market
• The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.

Industry Insights

• The increasing research & development activities for the treatment of Diabetic Macular Edema is likely to accelerate the growth of the Diabetic Macular Edema treatment market during the forecast period.
• Additionally, advancements in ophthalmic surgery techniques and R&D investment by pharmaceutical companies is further expected to boost the growth of the market in the years to come.
• The increasing medical costs for the patients and the frequent visits to the physicians is expected to hinder the growth of the market in the years to come.

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Regional Analysis: Preview

Based on region, the Global Diabetic Macular Edema Market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region led the market with the largest share in 2020. Some of the key countries contributing to the surge in the market are the U.S., U.K., Germany, France, China, India, Japan, and South Korea.

The market comprises of numerous small, medium, and large sized players spread across various geographies. Some of the main competitors in the Global Diabetic Macular Edema Market are Pfizer Inc., Bayer AG, Bausch & Lomb Incorporated, Allergan Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., ShahidBeheshti University of Medical Sciences., Johns Hopkins University, Novartis AG, The National Eye Institute.. The report covers company market share analysis which gives a comprehensive overview of the main competitors in the market. In addition, the report also covers major strategies adopted by market players such as new product launch, acquisitions & mergers, partnerships, collaborations & joint ventures, research & development, and regional expansion. The study also covers the product portfolio of major companies operating in the market.

The Global Diabetic Macular Edema Market can be categorized as Type, Application, End-Use Industry, and Region.